Gout - Treatment with a specified drug Factor
The RMA has specified that, subject to the mode of administration, dose level, minimum duration of treatment and temporality, the following drugs may be implicated as a causal factor or worsening factor for gout:
- Thiazide diuretics
- Frusemide
- Pyrazinamide
- Ethambutol
- Cyclosporine A
LAST REVIEWED FOR CCPS 01 JUNE 2000.
INVESTIGATIVE DOCUMENTS
|
Type |
Title |
PDF Format |
Word Format |
|---|---|---|---|
| Medical Report | Drug Treatment | MR9138.pdf | MR9138.docx |
PRELIMINARY QUESTIONS [24655]
24656 there is some evidence that being treated with a drug, as specified in the Statement of Principles for gout, may be a factor in the development or worsening of the condition under consideration.
30128 the veteran was treated with a drug as specified in the Statement of Principles for gout at some time.
24694 the veteran was treated with a drug as specified in the Statement of Principles for gout for an illness or injury which is identifiable. [Default true]
24657 the veteran has established the causal connection between being treated with a drug, as specified in the Statement of Principles for gout, and VEA service for gout.
24640 the veteran was treated with a drug as specified in the Statement of Principles for gout, for the identified illness or injury, before the clinical onset of the condition under consideration.
24658 the veteran has established the causal connection between being treated with a drug, as specified in the Statement of Principles for gout, and VEA service for the clinical onset of gout.
24660 the veteran has established the causal connection between being treated with a drug, as specified in the Statement of Principles for gout, and operational service for the clinical onset of gout.
or
24661 the veteran has established the causal connection between being treated with a drug, as specified in the Statement of Principles for gout, and eligible service for the clinical onset of gout.
or
7334 the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.
7335 the condition under consideration permanently worsened.
24644 the veteran was treated with a drug as specified in the Statement of Principles for gout, for the identified illness or injury, before the clinical worsening of the condition under consideration.
24659 the veteran has established the causal connection between being treated with a drug, as specified in the Statement of Principles for gout, and VEA service for the clinical worsening of gout.
24662 the veteran has established the causal connection between being treated with a drug, as specified in the Statement of Principles for gout, and operational service for the clinical worsening of gout.
or
24663 the veteran has established the causal connection between being treated with a drug, as specified in the Statement of Principles for gout, and eligible service for the clinical worsening of gout.
CLINICAL ONSET AND OPERATIONAL SERVICE [24660]
24641 the identified illness or injury, for which the veteran was treated with a drug as specified in the Statement of Principles for gout, is causally related to operational service.
CLINICAL ONSET AND ELIGIBLE SERVICE [24661]
24642 the identified illness or injury, for which the veteran was treated with a drug as specified in the Statement of Principles for gout, is causally related to eligible service.
CLINICAL WORSENING AND OPERATIONAL SERVICE [24662]
24641 the identified illness or injury, for which the veteran was treated with a drug as specified in the Statement of Principles for gout, is causally related to operational service.
24649 the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the veteran was treated with a drug as specified in the Statement of Principles for gout, is causally related.
CLINICAL WORSENING AND ELIGIBLE SERVICE [24663]
24642 the identified illness or injury, for which the veteran was treated with a drug as specified in the Statement of Principles for gout, is causally related to eligible service.
24650 the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the veteran was treated with a drug as specified in the Statement of Principles for gout, is causally related.